A tool that incorporates five predictors helps accurately identify patients with dermatomyositis who have an increased likelihood of concomitant cancer and can be used to help with early detection.

Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

The MHRA has approved tisotumab vedotin for adults with recurrent or metastatic cervical cancer, offering a new option after ...

IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...

Patients with chronic conditions in a French cohort often misestimate their physical activity levels; just over half meet the ...

Low daily step counts predict Parkinson's disease years before diagnosis but are likely a sign of early disease, not a risk ...

In children with cerebral palsy, surgery for scoliosis lowers the incidence of pneumonia requiring hospitalisation and the ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

Mental health services in England remain overstretched and fragmented, MPs warn, as stalled funding decisions threaten to ...

Many physicians aren’t as familiar with RVUs as they’d like to be. Here’s some advice about RVUs in employment contracts from an experienced attorney who represents physicians.

Women with obesity who discontinued GLP-1s were at increased risk for multiple adverse pregnancy outcomes than those who had ...